Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Topic TopicAgeingBiomarkers & diagnosticsCare & Home technologyCell biology of neurons & gliaGeneticsImmune systemLifestyle & environmentMolecular mechanismsSleep & Circadian rhythmsSynapse & CircuitryTreatments & InterventionsVascular system Dr Xiaotong Guo Postdoctoral Researcher Learn more Dr Xiaotong Guo Karnika Gupta PhD Student Learn more Karnika Gupta Samantha Gurumurthy Student Learn more Samantha Gurumurthy Dr Kiran Kumar Guruswamy Ravindran Postdoctoral Researcher Learn more Dr Kiran Kumar Guruswamy Ravindran Dr Emil Gustavsson Group Leader Interpreting genetic risk through transcriptomics to advance neurodegenerative therapies Learn more Dr Emil Gustavsson Dr Shlomi Haar Emerging Leader UK DRI Care Research & Technology at Imperial Developing digital biomarkers to detect and monitor disease progression and symptom fluctuation in neurodegeneration Learn more Dr Shlomi Haar Dr Barak Hadad Postdoctoral Researcher Learn more Dr Barak Hadad Anya Kaur Haddon MSc Student Learn more Anya Kaur Haddon Dr Kirsty Haddow Postdoctoral Researcher Learn more Dr Kirsty Haddow Charalambos Hadjipanayi PhD Student Learn more Charalambos Hadjipanayi Dr Cathleen Hagemann Postdoctoral Researcher Learn more Dr Cathleen Hagemann Jessica Hain Research Technician/ PhD student Learn more Jessica Hain Pagination First page First Previous page ‹ … Page 33 Page 34 Current page 35 Page 36 Page 37 … Next page › Last page Last
Dr Kiran Kumar Guruswamy Ravindran Postdoctoral Researcher Learn more Dr Kiran Kumar Guruswamy Ravindran
Dr Emil Gustavsson Group Leader Interpreting genetic risk through transcriptomics to advance neurodegenerative therapies Learn more Dr Emil Gustavsson
Dr Shlomi Haar Emerging Leader UK DRI Care Research & Technology at Imperial Developing digital biomarkers to detect and monitor disease progression and symptom fluctuation in neurodegeneration Learn more Dr Shlomi Haar
